Sivik Global Healthcare LLC Has $4.16 Million Position in Encompass Health Co. (NYSE:EHC)

Sivik Global Healthcare LLC decreased its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 10.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 45,000 shares of the company's stock after selling 5,000 shares during the quarter. Encompass Health accounts for about 2.2% of Sivik Global Healthcare LLC's investment portfolio, making the stock its 22nd biggest position. Sivik Global Healthcare LLC's holdings in Encompass Health were worth $4,156,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. MassMutual Private Wealth & Trust FSB lifted its holdings in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after acquiring an additional 137 shares during the period. UMB Bank n.a. lifted its stake in Encompass Health by 387.7% during the third quarter. UMB Bank n.a. now owns 317 shares of the company's stock worth $31,000 after purchasing an additional 252 shares during the period. V Square Quantitative Management LLC boosted its holdings in Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock valued at $39,000 after purchasing an additional 140 shares in the last quarter. Avior Wealth Management LLC bought a new stake in shares of Encompass Health in the 3rd quarter valued at approximately $40,000. Finally, Tompkins Financial Corp acquired a new position in shares of Encompass Health in the 4th quarter worth approximately $46,000. Institutional investors and hedge funds own 97.25% of the company's stock.

Encompass Health Price Performance

Shares of EHC stock traded up $1.24 during trading hours on Monday, reaching $100.51. 486,621 shares of the company were exchanged, compared to its average volume of 603,045. Encompass Health Co. has a fifty-two week low of $70.83 and a fifty-two week high of $104.55. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The stock's fifty day moving average is $96.52 and its two-hundred day moving average is $94.81. The company has a market cap of $10.13 billion, a price-to-earnings ratio of 24.29, a P/E/G ratio of 1.18 and a beta of 0.90.

Wall Street Analyst Weigh In

EHC has been the topic of several recent analyst reports. Truist Financial reaffirmed a "buy" rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Royal Bank of Canada upped their target price on shares of Encompass Health from $105.00 to $110.00 and gave the stock an "outperform" rating in a report on Wednesday, October 30th. Barclays lifted their price target on shares of Encompass Health from $109.00 to $116.00 and gave the company an "overweight" rating in a report on Tuesday, October 29th. Finally, KeyCorp upped their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the stock an "overweight" rating in a research note on Tuesday, October 29th. Nine research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, Encompass Health presently has an average rating of "Buy" and an average price target of $107.11.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.